Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMA: Privigen in CIDP
NCT01184846Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Nov 2010
- Primary completion
- Nov 2011
- Modality
- Biologic
- Countries
- 5
01
Overview
A Phase 3 trial of IgPro10 in chronic inflammatory demyelinating polyneuropathy (CIDP), sponsored by CSL Limited. Started Nov 2010; status: completed.
02
Drugs
IgPro10
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on NCT01184846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01184846.